Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anti-Microbial Savior BioteQ Co., Ltd. (6864:TWSE), powered by AI.
Anti-Microbial Savior BioteQ Co., Ltd. is currently trading at $48.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Anti-Microbial Savior BioteQ Co., Ltd. on Alpha Lenz.
View Anti-Microbial Savior BioteQ Co., Ltd.'s valuation metrics on Alpha Lenz.
“Anti-Microbial Savior BioteQ Co., Ltd.'s ROE is -25.0%. Explore profitability and growth together.”
Ask for details →Anti-Microbial Savior BioteQ Co., Ltd. is a biotechnology company specializing in the research and development of innovative pharmaceutical products, established in 2018 and headquartered in Kaohsiung, Taiwan. Its primary focus is on creating advanced antimicrobial solutions, including new classes of antibiotics designed to combat drug-resistant bacteria and viruses. The company is notable for its development and patenting of medicinal fungi and biomedical implants, as well as pioneering products such as artificial wound dressings (notably SIPSIPT), the antibacterial drug FORMOSA-1117, and the antiviral drug YUAN-03. These products are engineered to effectively manage challenging conditions like wounds with high exudate, overcome antibiotic-resistant bacterial infections, and inhibit viral replication at the cellular level. Anti-Microbial Savior BioteQ Co., Ltd. plays a significant role in the healthcare sector, contributing to the fight against the mounting threat of antimicrobial resistance and supporting advancements in global biomedical research and patient care through technology-driven innovation.
“Anti-Microbial Savior BioteQ Co., Ltd.'s ROE is -25.0%. Explore profitability and growth together.”
Ask for details →Anti-Microbial Savior BioteQ Co., Ltd. (ticker: 6864) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 48.95 with a P/E ratio of -x and P/B of -x.
ROE is -25.03% and operating margin is -13595.61%. Annual revenue is $706,000.